-transparent.png){kind=logo}
Nondepolarising muscle relaxants block neuromuscular transmission, acting as antagonists of the nicotinic receptors at the neuromuscular junction. Their undesired effects are frequently caused by interaction with acetylcholine receptors outside this junction, and autonomic cardiovascular effects may result. Other adverse effects include anaphylactic or anaphylactoid reactions, and histamine release. Various disease states may present specific considerations in the use of nondepolarising muscle relaxants. Although many complications of these drugs (such as prolonged block or resistance) are easily treated, others may necessitate immediate intervention and vigorous therapy. Careful selection of an appropriate relaxant for a particular patient will usually prevent the occurrence of complications.
M Abel, and
W J Book, and
J B Eisenkraft
January 1988,
Acta anaesthesiologica Belgica,
M Abel, and
W J Book, and
J B Eisenkraft
April 1989,
Acta anaesthesiologica Scandinavica,
M Abel, and
W J Book, and
J B Eisenkraft
January 2004,
Current allergy and asthma reports,
M Abel, and
W J Book, and
J B Eisenkraft
December 1998,
Anaesthesia,
M Abel, and
W J Book, and
J B Eisenkraft
January 1987,
British journal of anaesthesia,
M Abel, and
W J Book, and
J B Eisenkraft
January 1979,
International anesthesiology clinics,
M Abel, and
W J Book, and
J B Eisenkraft
April 1995,
Drug safety,
M Abel, and
W J Book, and
J B Eisenkraft
October 1998,
Drug safety,
M Abel, and
W J Book, and
J B Eisenkraft
April 1962,
British journal of anaesthesia,
